News

NDTV Profit on MSN1h
Wockhardt To Focus On Drug Discovery And Biologics: Chairman Khorakiwala On Exiting US Generics Business
Pharmaceutical major Wockhardt Ltd. is going to shift its focus to drug discovery and biologics after exiting the US generics ...
Optogenetic screening platform for drug discovery introduced
A new study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, ...
University of Chicago News22h
Chemical biologist links basic discoveries to treatments for disease
Prof. Hening Lin brings expertise in enzymes to UChicago, bridging scientists, engineers and doctors to translate research to ...
TMCnet23h
Integrated Biosciences Unveils First-of-Its-Kind Optogenetic Screening Platform for Drug Discovery
"Synthetic biology tools like optogenetics allow us to precisely tune complex cellular processes, something traditional drug screening cannot do," said Maxwell Wilson, Ph.D., Co-Founder and Chief ...
GEN - Genetic Engineering and Biotechnology News23h
Novel Optogenetics Drug Discovery Screening Platform Identifies Antivirals
A novel optogenetic screening platform enables a high-throughput screen and identified several integrated stress response-potentiating compounds.
Data mining uncovers treasure-trove of previously 'untouchable' proteins for drug development
Molecular glues, tiny molecules that connect one protein to another, are promising targets for pharmaceutical research. By ...
New AI tool models protein dynamics, aiding drug discovery and protein research
A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.
C&EN4d
Cancer drug Keytruda maker Merck buys Verona before patent cliff
A key patent for Merck’s blockbuster drug Keytruda will expire in 2028. The cancer therapy brought the company $29.5 billion last year. Keytruda may also face “ price setting ” from the Inflation ...